Deals & Cases

Deals & Cases

January 2012

Sale of Spirig's generic business to STADA Arzneimittel AG successfully completed

On January 31, 2012, the sale of Spirig Pharma AG's generics business to STADA Arzneimittel AG (XETRA: SAZ) was successfully completed.

Lenz & Staehelin advised the selling shareholders in this transaction. The Lenz & Staehelin team consisted of Rudolf Tschäni and Stephan Erni (both Corporate/M&A), Heini Rüdisühli and Stefan Schwaller (both Tax) and Peter Ling (IP).

Back